Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Sep;75(9):1270–1274. doi: 10.1136/jnnp.2003.030189

Alzheimer's disease—one clinical syndrome, two radiological expressions: a study on blood pressure

F-E de Leeuw 1, F Barkhof 1, P Scheltens 1
PMCID: PMC1739215  PMID: 15314113

Abstract

Background: Vascular risk factors could play a role in the aetiology of Alzheimer's disease, but this has not been investigated in relation to neuroimaging findings

Objective: To evaluate the distribution of blood pressure and an indicator of atherosclerosis (pulse pressure) in patients with Alzheimer's disease with and without small vessel disease.

Methods: 152 Alzheimer patients underwent 1.0T MRI scanning. Blood pressure was measured with a sphygmomanometer. Small vessel disease was assessed by the presence of lacunar infarcts and white matter lesions. The distribution of blood pressure and pulse pressure, with or without small vessel disease, was assessed by linear regression analysis.

Results: Patients with small vessel disease had a higher blood pressure, a wider pulse pressure, and an increased prevalence of hypertension. These findings were strongly age dependent: for patients under 65, mean systolic blood pressure was higher in the subpopulation with small vessel disease than in those without (mean (SD): 149.9 (19.3) v 135.7 (20.5) mm Hg; p = 0.02). Hypertension was more common in patients with white matter lesions than in those without (75.6% v 45.1%; p = 0.03) and the pulse pressure was higher (61.9 (14.4) v 51.7 (11.5) mm Hg; p = 0.01). There was no relation between blood pressure and the degree of (sub)cortical and hippocampal atrophy in patients without small vessel disease.

Conclusions: There was heterogeneity in Alzheimer's disease patients with respect to blood pressure and pulse pressure. Alzheimer's disease encompasses a heterogeneous group of disorders which share a common cognitive profile but with distinct radiological features with respect to white matter lesions.

Full Text

The Full Text of this article is available as a PDF (107.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams H. P., Jr, Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., Marsh E. E., 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35–41. doi: 10.1161/01.str.24.1.35. [DOI] [PubMed] [Google Scholar]
  2. De Groot Jan Cees, De Leeuw Frank-Erik, Oudkerk Matthijs, Van Gijn Jan, Hofman Albert, Jolles Jellemer, Breteler Monique M. B. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002 Sep;52(3):335–341. doi: 10.1002/ana.10294. [DOI] [PubMed] [Google Scholar]
  3. DeCarli C., Grady C. L., Clark C. M., Katz D. A., Brady D. R., Murphy D. G., Haxby J. V., Salerno J. A., Gillette J. A., Gonzalez-Aviles A. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):158–167. doi: 10.1136/jnnp.60.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doddy R. S., Massman P. J., Mawad M., Nance M. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol. 1998 Oct;11(4):191–199. [PubMed] [Google Scholar]
  5. Etiene Dannie, Kraft Joanny, Ganju Neema, Gomez-Isla Teresa, Gemelli Brad, Hyman Bradley T., Hedley-Whyte E. Tessa, Wands Jack R., De La Monte Suzanne M. Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease. J Alzheimers Dis. 1998 Dec;1(2):119–134. doi: 10.3233/jad-1998-1205. [DOI] [PubMed] [Google Scholar]
  6. Filley C. M. The behavioral neurology of cerebral white matter. Neurology. 1998 Jun;50(6):1535–1540. doi: 10.1212/wnl.50.6.1535. [DOI] [PubMed] [Google Scholar]
  7. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  8. Forette F., Seux M. L., Staessen J. A., Thijs L., Birkenhäger W. H., Babarskiene M. R., Babeanu S., Bossini A., Gil-Extremera B., Girerd X. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24;352(9137):1347–1351. doi: 10.1016/s0140-6736(98)03086-4. [DOI] [PubMed] [Google Scholar]
  9. Hansson L., Zanchetti A., Carruthers S. G., Dahlöf B., Elmfeldt D., Julius S., Ménard J., Rahn K. H., Wedel H., Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998 Jun 13;351(9118):1755–1762. doi: 10.1016/s0140-6736(98)04311-6. [DOI] [PubMed] [Google Scholar]
  10. Hofman A., Ott A., Breteler M. M., Bots M. L., Slooter A. J., van Harskamp F., van Duijn C. N., Van Broeckhoven C., Grobbee D. E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997 Jan 18;349(9046):151–154. doi: 10.1016/S0140-6736(96)09328-2. [DOI] [PubMed] [Google Scholar]
  11. Lopez O. L., Becker J. T., Jungreis C. A., Rezek D., Estol C., Boller F., DeKosky S. T. Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol. 1995 Jul;52(7):659–664. doi: 10.1001/archneur.1995.00540310029012. [DOI] [PubMed] [Google Scholar]
  12. Mann D. M., Yates P. O., Marcyniuk B. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci. 1985 Jul;69(3):139–159. doi: 10.1016/0022-510x(85)90129-7. [DOI] [PubMed] [Google Scholar]
  13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  14. Nagy Z., Esiri M. M., Jobst K. A., Morris J. H., King E. M., McDonald B., Joachim C., Litchfield S., Barnetson L., Smith A. D. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol. 1997 Feb;56(2):165–170. doi: 10.1097/00005072-199702000-00007. [DOI] [PubMed] [Google Scholar]
  15. Ott A., Breteler M. M., de Bruyne M. C., van Harskamp F., Grobbee D. E., Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997 Feb;28(2):316–321. doi: 10.1161/01.str.28.2.316. [DOI] [PubMed] [Google Scholar]
  16. Ott A., Stolk R. P., van Harskamp F., Pols H. A., Hofman A., Breteler M. M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999 Dec 10;53(9):1937–1942. doi: 10.1212/wnl.53.9.1937. [DOI] [PubMed] [Google Scholar]
  17. Scheltens P., Barkhof F., Valk J., Algra P. R., van der Hoop R. G., Nauta J., Wolters E. C. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain. 1992 Jun;115(Pt 3):735–748. doi: 10.1093/brain/115.3.735. [DOI] [PubMed] [Google Scholar]
  18. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H. C., Vermersch P., Kuiper M., Steinling M., Wolters E. C., Valk J. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967–972. doi: 10.1136/jnnp.55.10.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shepherd James, Blauw Gerard J., Murphy Michael B., Bollen Edward L. E. M., Buckley Brendan M., Cobbe Stuart M., Ford Ian, Gaw Allan, Hyland Michael, Jukema J. Wouter. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002 Nov 23;360(9346):1623–1630. doi: 10.1016/s0140-6736(02)11600-x. [DOI] [PubMed] [Google Scholar]
  20. Skoog I., Nilsson L., Palmertz B., Andreasson L. A., Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993 Jan 21;328(3):153–158. doi: 10.1056/NEJM199301213280301. [DOI] [PubMed] [Google Scholar]
  21. Sullivan E. V., Shear P. K., Mathalon D. H., Lim K. O., Yesavage J. A., Tinklenberg J. R., Pfefferbaum A. Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease. Arch Neurol. 1993 Apr;50(4):359–373. doi: 10.1001/archneur.1993.00540040021009. [DOI] [PubMed] [Google Scholar]
  22. Vermeer Sarah E., Den Heijer Tom, Koudstaal Peter J., Oudkerk Matthijs, Hofman Albert, Breteler Monique M. B., Rotterdam Scan Study Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003 Feb;34(2):392–396. doi: 10.1161/01.str.0000052631.98405.15. [DOI] [PubMed] [Google Scholar]
  23. Whitman G. T., Tang Y., Lin A., Baloh R. W., Tang T. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology. 2001 Sep 25;57(6):990–994. doi: 10.1212/wnl.57.6.990. [DOI] [PubMed] [Google Scholar]
  24. de Groot J. C., de Leeuw F. E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M. M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000 Feb;47(2):145–151. doi: 10.1002/1531-8249(200002)47:2<145::aid-ana3>3.3.co;2-g. [DOI] [PubMed] [Google Scholar]
  25. de Leeuw F-E, de Groot J. C., Oudkerk M., Witteman J. C. M., Hofman A., van Gijn J., Breteler M. M. B. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002 Apr;125(Pt 4):765–772. doi: 10.1093/brain/awf077. [DOI] [PubMed] [Google Scholar]
  26. de Leeuw F. E., De Groot J. C., Oudkerk M., Witteman J. C., Hofman A., van Gijn J., Breteler M. M. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke. 2000 Feb;31(2):425–429. doi: 10.1161/01.str.31.2.425. [DOI] [PubMed] [Google Scholar]
  27. de Leeuw F. E., de Groot J. C., Bots M. L., Witteman J. C., Oudkerk M., Hofman A., van Gijn J., Breteler M. M. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol. 2000 Apr;247(4):291–296. doi: 10.1007/s004150050586. [DOI] [PubMed] [Google Scholar]
  28. van Gool W. A., Eikelenboom P. The two faces of Alzheimer's disease. J Neurol. 2000 Jul;247(7):500–505. doi: 10.1007/s004150070147. [DOI] [PubMed] [Google Scholar]
  29. van Popele N. M., Grobbee D. E., Bots M. L., Asmar R., Topouchian J., Reneman R. S., Hoeks A. P., van der Kuip D. A., Hofman A., Witteman J. C. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001 Feb;32(2):454–460. doi: 10.1161/01.str.32.2.454. [DOI] [PubMed] [Google Scholar]
  30. van Zagten M., Kessels F., Boiten J., Lodder J. Interobserver agreement in the assessment of cerebral atrophy on CT using bicaudate and sylvian-fissure ratios. Neuroradiology. 1999 Apr;41(4):261–264. doi: 10.1007/s002340050743. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES